LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Clinical trials for LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Timing is everything: new trial seeks to boost cancer treatment by scheduling immunotherapy just right
Disease control Not yet recruitingThis Phase II trial tests whether giving the immunotherapy drug toripalimab on different days during chemotherapy can improve outcomes for people with advanced nasopharyngeal cancer. About 198 participants will receive standard chemotherapy plus toripalimab on Day 1, Day 5, or Da…
Matched conditions: LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could immunotherapy replace chemo in nasopharyngeal cancer?
Disease control Not yet recruitingThis phase III trial tests whether adding the immunotherapy drug serplulimab to standard induction chemotherapy can allow patients with advanced nasopharyngeal cancer to skip concurrent chemotherapy during radiation. The study plans to enroll 456 adults aged 18-65 with stage II-I…
Matched conditions: LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 26, 2026 18:11 UTC